NCT06154863 2024-02-20
Recurrence in Patients With Differentiated Thyroid Cancer
Assiut University
Unknown
Clinical Trials
12 trialsNCT04447183 2023-10-23
DTC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Unknown
NCT04964284 2023-10-23
Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Unknown
NCT04858867 2023-10-10
RESET
Leiden University Medical Center
Phase NA Unknown
NCT04391244 2023-08-18
INSPIRE
Royal Marsden NHS Foundation Trust
Unknown
NCT03048877 2023-04-12
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT01263951 2021-10-26
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
Thomas Jefferson University
Phase 2 Unknown
NCT04880798 2021-05-11
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase NA Unknown
NCT04857086 2021-04-23
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
Huazhong University of Science and Technology
Unknown
NCT04563780 2021-02-04
The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer
Assiut University
Unknown
NCT02586337 2019-05-21
Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2/3 Unknown
NCT02638077 2015-12-22
DTCC
Huazhong University of Science and Technology
Unknown